TuisIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Vorige sluiting
$75,16
Dagwisseling
$73,15 - $75,16
Jaarwisseling
$23,95 - $86,74
Markkapitalisasie
12,23 mjd USD
Gemiddelde volume
2,24 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 203,33 m | -10,26% |
Bedryfskoste | 130,19 m | 47,81% |
Netto inkomste | -229,39 m | -119,83% |
Netto winsgrens | -112,82 | -144,99% |
Wins per aandeel | -1,15 | -166,75% |
EBITDA | -210,56 m | -94,74% |
Effektiewe belastingkoers | -0,65% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,68 mjd | 16,39% |
Totale bates | 3,52 mjd | 17,32% |
Totale aanspreeklikheid | 3,03 mjd | 25,65% |
Totale ekwiteit | 489,09 m | — |
Uitstaande aandele | 165,19 m | — |
Prys om te bespreek | 25,14 | — |
Opbrengs op bates | -16,35% | — |
Opbrengs op kapitaal | -18,58% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -229,39 m | -119,83% |
Kontant van bedrywe | -137,71 m | -18,57% |
Kontant van beleggings | -419,50 m | -714,99% |
Kontant van finansiering | 591,18 m | 1 440,05% |
Netto kontantverandering | 33,92 m | 136,66% |
Beskikbare kontantvloei | -84,56 m | 25,19% |
Meer oor
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
Gestig
1989
Hoofkwartier
Webwerf
Werknemers
1 402
